LRN vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

LRN

41.8
AI Score
VS
UTI Wins

UTI

45.4
AI Score

Investment Advisor Scores

LRN

42score
Recommendation
HOLD

UTI

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LRN UTI Winner
Forward P/E 9.3721 35.5872 LRN
PEG Ratio 0.4686 2.3751 LRN
Revenue Growth -2.7% 7.2% UTI
Earnings Growth 69.6% -78.9% LRN
Tradestie Score 41.8/100 45.4/100 UTI
Profit Margin 13.4% 3.9% LRN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LRN 1M: -2.0% · 3M: -3.8% UTI 1M: -42.2% · 3M: -38.9%

Current Technical Phase

LRN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $84.36

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $22.35

Fundamentals Snapshot

Metric LRN UTI
Market Cap
Forward P/E 9.7 30.4
Trailing P/E 11.8 39.5
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.6%
Operating Margin 0.2% 0.0%
EPS 7.13 0.58
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.